TP53 and colorectal carcinoma: Further studies reported 5-FU pre-treatment to radiosensitize CRC cells through p38 MAPK and wt-p53 activation, indicating a cooperativity of either chemotherapy potentiating RT or vice-versa [50] (Figure 2B).